Search research articles
Contact Us
Filters
Showing results (141-150 of 171) with videos related to
Page
of 18
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
December 23, 2010
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer
Sara Margolin, Nils-Olof Bengtsson, Lena Carlsson, et al.
Plos Medicine
|
January 6, 2026
Sex-specific associations between surgery-induced weight loss and cancer outcomes: A post hoc analysis of the prospective, controlled Swedish Obese Subjects study
Kajsa Sjöholm, Per-Arne Svensson, Johanna C Andersson-Assarsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2019
Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer
Martin Sjöström, S Laura Chang, Nick Fishbane, et al.
Breast Cancer Research and Treatment
|
December 1, 2017
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
Alexios Matikas, Sara Margolin, Mats Hellström, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2020
Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Henri A J Puttonen, Martin Sjöström, et al.
Plos One
|
June 20, 2014
Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies
Krister Blodörn, Sara Hägglund, Jenna Fix, et al.
Cancers
|
December 10, 2021
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
Fredrik Wärnberg, Per Karlsson, Erik Holmberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2023
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
Martin Sjöström, Anthony Fyles, Fei-Fei Liu, et al.
Annals of Surgery
|
May 19, 2011
Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: a national survey
Brita Arver, Karin Isaksson, Hans Atterhem, et al.
Molecular Therapy. Oncology
|
August 8, 2025
Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics
Lucas Werner, Ella Ittner, Hugo Swenson, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 171) with videos related to
Sort By:
Page
of 18
Acta Oncologica (Stockholm, Sweden)
|
December 23, 2010
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer
Sara Margolin, Nils-Olof Bengtsson, Lena Carlsson, et al.
Plos Medicine
|
January 6, 2026
Sex-specific associations between surgery-induced weight loss and cancer outcomes: A post hoc analysis of the prospective, controlled Swedish Obese Subjects study
Kajsa Sjöholm, Per-Arne Svensson, Johanna C Andersson-Assarsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2019
Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer
Martin Sjöström, S Laura Chang, Nick Fishbane, et al.
Breast Cancer Research and Treatment
|
December 1, 2017
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
Alexios Matikas, Sara Margolin, Mats Hellström, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2020
Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Henri A J Puttonen, Martin Sjöström, et al.
Plos One
|
June 20, 2014
Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies
Krister Blodörn, Sara Hägglund, Jenna Fix, et al.
Cancers
|
December 10, 2021
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
Fredrik Wärnberg, Per Karlsson, Erik Holmberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2023
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
Martin Sjöström, Anthony Fyles, Fei-Fei Liu, et al.
Annals of Surgery
|
May 19, 2011
Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: a national survey
Brita Arver, Karin Isaksson, Hans Atterhem, et al.
Molecular Therapy. Oncology
|
August 8, 2025
Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics
Lucas Werner, Ella Ittner, Hugo Swenson, et al.
Page
of 18